Dr Sue Pavord:’It was scary. I was a mother of three kids in their 20s, and these were the people we were seeing dying’ - Christopher Pledger When Oxford University developed the AstraZeneca vaccine, ...
Seven years after the FDA's accelerated approval of bleeding reversal agent Andexxa, which was then under the ownership of ...
Right now, much of the buzz surrounding the market for anti-obesity medicines is based on the idea that taking certain drugs can help those suffering from obesity to shed enough pounds to reach a ...
While AstraZeneca has announced that it will participate in the 2026 JP Morgan Healthcare Conference, it hasn’t yet revealed details about its presentation.
Pharmaceutical Technology on MSN
AstraZeneca pulls Andexxa from US market after post-marketing fatalities
Andexxa pulled in $219m in sales globally in 2024, with $81m of this profit coming from the US. "AstraZeneca pulls Andexxa ...
AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. Pfizer CEO Albert Bourla appeared with ...
Pharma companies are seeing the value of digital health, and are creating departments focused on developing, scaling and investing in platforms that use technology to enhance life sciences R&D, better ...
Pharma giant AstraZeneca (AZN) is scheduled to announce its third-quarter results on Tuesday, November 12. Wall Street expects the company to report Q3 earnings per share (EPS) of $1.02, reflecting a ...
Pharma giant AstraZeneca has expanded its supply deal with Michigan-based medical radioisotope producer Niowave, establishing ...
In 2017, viewers of the pilot episode of Hulu’s “The Handmaid’s Tale” found themselves identifying to an excruciating degree with the agonies of the title character, played by Elizabeth Moss, as ...
AstraZeneca's aldosterone synthase inhibitor baxdrostat reduced blood pressure by 14 mmHg over 12 weeks, the pharma has said in a first look at the data from a key phase 3 win. Baxdrostat has a ...
Gulf Business on MSNOpinion
Incesu explains why NMOSD is so often misdiagnosed and what it will take for rare diseases to gain a stronger foothold within national health strategies
Incesu explains on NMOSD and what it will take for rare diseases to gain a stronger foothold within national health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback